Analysis | Metabolite Name | Measured Value | Units | Age Group | Sex | Smoking Status | Diagnosis |
---|---|---|---|---|---|---|---|
GC POSITIVE ION MODE | pyruvic acid | 59 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 63 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 64 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 64 | Counts | 60-64 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | pyruvic acid | 65 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 66 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 72 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | pyruvic acid | 72 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | pyruvic acid | 72 | Counts | 60-64 | Female | Current | Other NSCLC |
GC POSITIVE ION MODE | pyruvic acid | 72 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 73 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 77 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 80 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 80 | Counts | 60-64 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | pyruvic acid | 82 | Counts | 65-69 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | pyruvic acid | 83 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 90 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 95 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 98 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 101 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 107 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 107 | Counts | 65-69 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | pyruvic acid | 108 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 109 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | pyruvic acid | 112 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 113 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 113 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 115 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 119 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 121 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 121 | Counts | 65-69 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | pyruvic acid | 128 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 130 | Counts | 55-59 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | pyruvic acid | 130 | Counts | 65-69 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | pyruvic acid | 131 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 140 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 143 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 145 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | pyruvic acid | 146 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 147 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 150 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 150 | Counts | 50-54 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | pyruvic acid | 156 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 158 | Counts | 50-54 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 158 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | pyruvic acid | 159 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 161 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 169 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 177 | Counts | 55-59 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | pyruvic acid | 187 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 188 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 201 | Counts | 65-69 | Female | Former | Other NSCLC |
GC POSITIVE ION MODE | pyruvic acid | 203 | Counts | 50-54 | Female | Former | Other NSCLC |
GC POSITIVE ION MODE | pyruvic acid | 618 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 675 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 736 | Counts | 55-59 | Female | Current | Other NSCLC |
GC POSITIVE ION MODE | pyruvic acid | 831 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 960 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 980 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | pyruvic acid | 1007 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 1008 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 1028 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 1106 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 1118 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 1241 | Counts | 65-69 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | pyruvic acid | 1257 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | pyruvic acid | 1304 | Counts | 50-54 | Female | Current | Other NSCLC |
GC POSITIVE ION MODE | pyruvic acid | 1318 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 1357 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 1358 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 1439 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 1440 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 1443 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 1457 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 1476 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 1493 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 1495 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 1551 | Counts | 65-69 | Female | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 1563 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 1641 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 1661 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 1667 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 1678 | Counts | 55-59 | Female | Current | Squamous cell |
GC POSITIVE ION MODE | pyruvic acid | 1696 | Counts | 50-54 | Female | Current | Other NSCLC |
GC POSITIVE ION MODE | pyruvic acid | 1716 | Counts | 50-54 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | pyruvic acid | 1749 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 1793 | Counts | 65-69 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | pyruvic acid | 1804 | Counts | 50-54 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | pyruvic acid | 1873 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 1876 | Counts | 60-64 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | pyruvic acid | 1880 | Counts | 60-64 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | pyruvic acid | 1886 | Counts | 45-49 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | pyruvic acid | 1899 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 1928 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | pyruvic acid | 1946 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | pyruvic acid | 2057 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 2079 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 2108 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 2109 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 2147 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 2157 | Counts | 60-64 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | pyruvic acid | 2195 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 2202 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 2269 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | pyruvic acid | 2282 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 2294 | Counts | 60-64 | Female | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 2316 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 2361 | Counts | 65-69 | Female | Former | Adenocarcinoma |
GC POSITIVE ION MODE | pyruvic acid | 2424 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 2468 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | pyruvic acid | 2484 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 2495 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 2498 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 2536 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 2556 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 2576 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 2626 | Counts | 55-59 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | pyruvic acid | 2662 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 2668 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | pyruvic acid | 2791 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 2829 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 2896 | Counts | 50-54 | Female | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 2925 | Counts | 65-69 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | pyruvic acid | 2929 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 2938 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 2957 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 2969 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | pyruvic acid | 2975 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | pyruvic acid | 3029 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 3057 | Counts | 65-69 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | pyruvic acid | 3077 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 3090 | Counts | 50-54 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | pyruvic acid | 3101 | Counts | 50-54 | Female | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 3103 | Counts | 70-74 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | pyruvic acid | 3109 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 3125 | Counts | 60-64 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | pyruvic acid | 3166 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 3230 | Counts | 65-69 | Female | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 3236 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 3244 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 3281 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 3316 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | pyruvic acid | 3319 | Counts | 70-74 | Male | Former | Other NSCLC |
GC POSITIVE ION MODE | pyruvic acid | 3339 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 3407 | Counts | 65-69 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | pyruvic acid | 3415 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 3418 | Counts | 60-64 | Female | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 3430 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 3449 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | pyruvic acid | 3539 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 3557 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 3649 | Counts | 55-59 | Female | Current | Adenocarcinoma |
GC POSITIVE ION MODE | pyruvic acid | 3664 | Counts | 70-74 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | pyruvic acid | 3665 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 3686 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 3718 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 3735 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 3763 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 3766 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 3775 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 3889 | Counts | 55-59 | Female | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 3902 | Counts | 70-74 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 3903 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | pyruvic acid | 3922 | Counts | 45-49 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 3935 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 3938 | Counts | 60-64 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | pyruvic acid | 4128 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 4157 | Counts | 60-64 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | pyruvic acid | 4159 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 4166 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 4180 | Counts | 65-69 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | pyruvic acid | 4234 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 4237 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | pyruvic acid | 4241 | Counts | 55-59 | Male | Former | Adenocarcinoma |
GC POSITIVE ION MODE | pyruvic acid | 4275 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 4284 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | pyruvic acid | 4301 | Counts | 55-59 | Male | Former | Squamous cell |
GC POSITIVE ION MODE | pyruvic acid | 4413 | Counts | 50-54 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 4444 | Counts | 65-69 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 4455 | Counts | 55-59 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 4486 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | pyruvic acid | 4490 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 4494 | Counts | 50-54 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 4576 | Counts | 65-69 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | pyruvic acid | 4675 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 4846 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 4865 | Counts | 60-64 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 4911 | Counts | 55-59 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | pyruvic acid | 4959 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 4985 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 5064 | Counts | 55-59 | Male | Current | Squamous cell |
GC POSITIVE ION MODE | pyruvic acid | 5065 | Counts | 55-59 | Male | Former | - |
GC POSITIVE ION MODE | pyruvic acid | 5094 | Counts | 65-69 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 5155 | Counts | 60-64 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | pyruvic acid | 5210 | Counts | 50-54 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 5305 | Counts | 60-64 | Male | Current | - |
GC POSITIVE ION MODE | pyruvic acid | 5420 | Counts | 55-59 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | pyruvic acid | 5426 | Counts | 50-54 | Male | Current | Adenocarcinoma |
GC POSITIVE ION MODE | pyruvic acid | 5667 | Counts | 65-69 | Male | Current | Other NSCLC |
GC POSITIVE ION MODE | pyruvic acid | 5701 | Counts | 50-54 | Male | Former | - |
Return to search page